ArticleJournal of neurologic physical therapy : JNPT2026
The Influence of Motor and Nonmotor Factors on Ambulatory Activity in People With Parkinson Disease.
Article in Journal of neurologic physical therapy : JNPT, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
background and purposeReduction in ambulation levels has been described as a clinical "red flag" that represents the emergence of disability in individuals with Parkinson disease (PD). Multiday ambulatory activity measures may capture disability not detected by standard clinical assessments. However, the influence of disease severity and nonmotor symptoms on ambulatory activity remains unclear. This study aimed to examine the association between daily ambulatory activity and motor disease severity, assessed in both medication states, and to identify which non-motor symptoms were associated with daily step accumulation in individuals with mild to moderate PD.
methodsMean daily steps were calculated over 7 days in 198 participants with PD. Motor and nonmotor symptoms were characterized using Movement Disorders Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS) Part I, III, and IV. Descriptive statistics were calculated at baseline to characterize participant demographics and clinical characteristics. Linear regressions modeled the association between motor/nonmotor signs/symptoms and ambulatory activity, adjusting for age, race, and body mass index.
resultsMedian daily step count was 5180 (interquartile range: 3521-7199). Standardized off-medication MDS-UPDRS III scores were significantly associated with fewer mean daily steps, while on-medication scores were not, though the magnitude of this association was modest. Among nonmotor symptoms, a self-reported complaint of lightheadedness upon standing was associated with approximately 2000 fewer mean daily steps.
conclusionA self-report of lightheadedness upon standing showed a clinically meaningful association with reduced ambulatory activity, while motor severity, even assessed in the standardized off-medication state, showed only a modest association. These findings highlight the value of nonmotor symptom assessment, particularly cardiovascular autonomic screening, in understanding real-world disability in PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.